Maravai LifeSciences Holdings, Inc. Payments to Noncontrolling Interests
Maravai LifeSciences Holdings, Inc. (MRVI) reported Payments to Noncontrolling Interests of $9.61 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToMinorityShareholders · last filed 2023-11-08
- Maravai LifeSciences Holdings, Inc. payments to noncontrolling interests for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. payments to noncontrolling interests for the quarter ending 2023-06-30 was $1.30M, a 96.94% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. payments to noncontrolling interests for the quarter ending 2023-03-31 was $8.30M, a 79.19% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. payments to noncontrolling interests for the quarter ending 2022-12-31 was -$119.29M.
- Maravai LifeSciences Holdings, Inc. payments to noncontrolling interests for fiscal 2022 was $0.00.
- Maravai LifeSciences Holdings, Inc. payments to noncontrolling interests for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Maravai LifeSciences Holdings, Inc. payments to noncontrolling interests for fiscal 2020 was $120.00M.
- Maravai LifeSciences Holdings, Inc. payments to noncontrolling interests for fiscal 2019 was $0.00.
| Period end | Payments to Noncontrolling Interests 3 month | Payments to Noncontrolling Interests 6 month | Payments to Noncontrolling Interests 9 month | Payments to Noncontrolling Interests 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.30M derived: sum of 2 quarters · filed 2023-11-08 | $9.61M 10-Q · filed 2023-11-08 | -$109.68M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $9.61M 10-Q · filed 2023-08-08 | -$109.68M derived: sum of 3 quarters · filed 2023-08-08 | -$72.87M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-03-31 | $8.30M 10-Q · filed 2023-05-09 | -$110.99M derived: sum of 2 quarters · filed 2023-05-09 | -$74.17M derived: sum of 3 quarters · filed 2023-11-08 | -$31.59M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-12-31 | -$119.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$82.48M derived: sum of 2 quarters · filed 2023-11-08 | -$39.89M derived: sum of 3 quarters · filed 2023-11-08 | $0.00 10-K · filed 2023-02-28 |
| 2022-09-30 | $36.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $79.40M derived: sum of 2 quarters · filed 2023-11-08 | $119.29M 10-Q · filed 2023-11-08 | $12.99M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $42.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $82.48M 10-Q · filed 2023-08-08 | -$23.82M derived: sum of 3 quarters · filed 2023-08-08 | $26.27M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $39.89M 10-Q · filed 2023-05-09 | -$66.41M derived: sum of 2 quarters · filed 2023-05-09 | -$16.31M derived: sum of 3 quarters · filed 2023-05-09 | $16.76M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$106.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$56.20M derived: sum of 2 quarters · filed 2023-02-28 | -$23.13M derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 |
| 2021-09-30 | $50.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $83.17M derived: sum of 2 quarters · filed 2022-11-04 | $106.30M 10-Q · filed 2022-11-04 | $225.99M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $33.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $56.20M 10-Q · filed 2022-08-05 | $175.90M derived: sum of 3 quarters · filed 2023-02-28 | $176.02M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $23.13M 10-Q · filed 2022-05-06 | $142.82M derived: sum of 2 quarters · filed 2023-02-28 | $142.94M derived: sum of 3 quarters · filed 2023-02-28 | $143.13M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $119.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $119.81M derived: sum of 2 quarters · filed 2023-02-28 | $120.00M derived: sum of 3 quarters · filed 2023-02-28 | $120.00M 10-K · filed 2023-02-28 |
| 2020-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $312.00K derived: sum of 2 quarters · filed 2021-11-15 | $312.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $190.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |